reports
Biomerica Announces inFoods® IBS Pilot Launch with Prominent 1,100 Mem...
Biomerica Announces inFoods® IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024 With IBS affecting 10 to 15% of the global population, the associated $21 billion in direct medical costs and absenteeism underscores the urgent need of innovative solutions. Recognized as the 7th most common diagnosis by all physicians, IBS represents a significant healthcare burden. inFoods IBS offers a groundbreaking method to identify foods that can trigger IBS symptoms, revolutionizing how IBS symptoms are managed. inFoods IBS is backed by extensive clinical research that ha...
Chang Lan Technology Group Co Ltd: 1 director
A director at Chang Lan Technology Group Co Ltd maiden bought 705,000 shares at 14.160CNY and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ov...
Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of S...
Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia – SENTI-202 is a potential first-in-class Logic Gated off-the-shelf CAR-NK cell therapy – – Initial clinical efficacy data expected by year-end 2024 and durability data expected in 2025 – SOUTH SAN FRANCISCO, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circui...
Benitec Biopharma Releases Third Quarter 2024 Financial Results and Pr...
Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational Update -Positive Interim Clinical Trial Data for the First Oculopharyngeal Muscular Dystrophy (OPMD) Subject Dosed with BB-301 in the Phase 1b/2a Clinical Treatment Study Reported in April- -The Second OPMD Subject was Safely Dosed with BB-301 in February- -Additional Interim Clinical Safety Data and Clinical Efficacy Data are Expected for Several Study Subjects in the Second Half of 2024- -23 OPMD Subjects have Enrolled into the OPMD Natural History Study with Multiple Subjects Eligible for Entry i...
Royalty Pharma to Present at Upcoming Investor Conferences
Royalty Pharma to Present at Upcoming Investor Conferences NEW YORK, May 13, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in the following upcoming investor conferences during the month of May: RBC Capital Markets 2024 Global Healthcare Conference on Tuesday, May 14 at 9:00 a.m. ETBofA Securities 2024 Healthcare Conference on Wednesday, May 15 at 6:00 p.m. ET / 3:00 p.m. PT The webcasts will be accessible from Royalty Pharma’s “Events” page at . Webcasts will also be archived for a minimum of thirty days. About Royalty Pharma Fou...
Ocean Power Technologies Announces Renewable Energy Production Milesto...
Ocean Power Technologies Announces Renewable Energy Production Milestone Approaches 15MWh of Renewable Energy Production MONROE TOWNSHIP, N.J., May 13, 2024 (GLOBE NEWSWIRE) -- Ocean Power Technologies, Inc. (NYSE American: OPTT) (“OPT” or the “Company”), a leader in innovative and cost-effective low-carbon marine power, data, and service solutions, today announced it is approaching 15MWh of renewable energy production from its family of PowerBuoys ® (“PB”). The recent launch of its Next Generation PB off the coast of New Jersey has materially accelerated average energy production by co...
EQS-News: vbw Pressemitteilung: vbw 'Weißbier-Index' fällt im Frühjahr...
Emittent / Herausgeber: ibw – Informationszentrale der Bayerischen Wirtschaft e. V. / Schlagwort(e): Sonstiges/Sonstiges vbw Pressemitteilung: vbw 'Weißbier-Index' fällt im Frühjahr 2024 von 93 auf 87 Punkte 13.05.2024 / 14:07 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Pressemitteilung zum vbw Index Frühjahr 2024 vbw „Weißbier-Index“ fällt von 93 auf 87 Punkte Wirtschaft verharrt in Stagnation zunehmende Risiken für den Arbeitsmarkt Bundesregierung muss endlich den Schalter umlegen (München, 13.05.2024). Aus Sicht der vbw – ...
DFCC Bank: 1 director
A director at DFCC Bank bought 148,059 shares at 81.461LKR and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
- ABGSC Capital Goods Research
- Anders Idborg
- Karl Bokvist
- Olof Cederholm
Scandinavian Tobacco Group A/S: Transactions in connection with share ...
Scandinavian Tobacco Group A/S: Transactions in connection with share buy-back programme Company Announcement No. 27/2024 Copenhagen, 13 May 2024 Transactions in connection with share buy-back programme On 10 November 2023, Scandinavian Tobacco Group A/S announced that a share buy-back programme of an aggregated value of up to DKK 850 million was launched with the purpose to adjust the Company’s capital structure and meet obligations relating to the Group’s share-based incentive programme. Part of the programme will be conducted in accordance with Regulation No. 596/2014 of the Eur...
Hardman & Co Research on NB Private Equity Partners (NBPE): Wider oper...
Hardman & Co Research Hardman & Co Research on NB Private Equity Partners (NBPE): Wider operating company EBITDA margins in 2023 13-May-2024 / 13:07 GMT/BST The issuer is solely responsible for the content of this announcement. Hardman & Co Research | Investment Companies NB Private Equity Partners (NBPE) | Wider operating company EBITDA margins in 2023 We reviewed NBPE’s business model in our initiation, . We noted the high-secular-growth and downside-resilient investee companies, the value added by GPs, the good co-investing cashflow and return profile and the value add...
CNMC Goldmine Holdings Limited: 1 director
A director at CNMC Goldmine Holdings Limited sold 4,600,000 shares at 0.210SGD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last ...
Moody's Ratings assigns provisional ratings to Consumer ABS Notes to b...
Moody's Ratings ("Moody's") has assigned the following provisional ratings to Notes to be issued by Mila 2024-1 B.V.: ....EUR [ ]M Class A asset-backed Notes 2024 due 2041, Assigned (P)Aaa (sf) ....EUR [ ]M Class B asset-backed Notes 2024 due 2041, Assigned (P)Aa3 (sf) ....EUR [ ]M Class C asset...
Cheetah Net Supply Chain Service Inc. Announces 1st Quarter 2024 Resul...
Cheetah Net Supply Chain Service Inc. Announces 1st Quarter 2024 Results and Provides Corporate Update CHARLOTTE, N.C., May 13, 2024 (GLOBE NEWSWIRE) -- Cheetah Net Supply Chain Service Inc. (“Cheetah” or the “Company”) (Nasdaq CM: CTNT), a supplier of parallel-import vehicles sourced in the U.S. to be sold in the People’s Republic of China (the “PRC”) market, today reported results for the quarter ended March 31, 2024 and provided a corporate update. Recent Highlights Challenging market conditions in the PRC, first reported with respect to the Company’s financial performance during the...
Terns Pharmaceuticals Reports First Quarter 2024 Financial Results and...
Terns Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Updates Interim data from initial dose escalation cohorts from Phase 1 CARDINAL trial of TERN-701 (allosteric BCR-ABL) in CML expected in 2H24 Top-line data from Phase 1 trial of TERN-601 (oral GLP-1) for obesity expected in 2H24 Cash, cash equivalents and marketable securities of $241 million, expected to provide runway into 2026 FOSTER CITY, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical stage biopharmaceutical company developing...
Graham Corporation Announces Filing of Universal Shelf Registration St...
BATAVIA, N.Y.--(BUSINESS WIRE)-- (NYSE: GHM) (“GHM” or “the Company”), a global leader in the design and manufacture of mission critical fluid, power, heat transfer and vacuum technologies for the defense, space, energy, and process industries, announced today that it has filed a universal shelf registration statement on Form S-3 with the Securities and Exchange Commission (SEC). If and when the shelf registration is declared effective, it will permit the Company to offer and sell, from time to time in one or more offerings, up to $150 million of common stock, preferred stock, warrants, purch...
Holding(s) in Company
easyJet plc (EZJ) Holding(s) in Company 13-May-2024 / 13:00 GMT/BST TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00B7KR2P84 Issuer Name EASYJET PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name Bank of America Corporation City of registered office (if applicable) Country of registered office (if applicable) US 4. Details of the shareholder Full name of shareholder(...
EQS-News: Canada-United States (US) collaboration in Africa under disc...
EQS-News: The Canada-Africa Chamber of Business / Key word(s): Miscellaneous Canada-United States (US) collaboration in Africa under discussion on May 22nd in Washington, DC 13.05.2024 / 08:00 EST/EDT The issuer is solely responsible for the content of this announcement. Canada-United States (US) collaboration in Africa under discussion on May 22nd in Washington, DC The Lobito Corridor will serve as one example of opportunities for deepening trade and investment partnerships in Africa, through networking and information-sharing at the inaugural private sector forum T...
CSW Industrials Announces Date for Fiscal Fourth Quarter and Full Year...
CSW Industrials Announces Date for Fiscal Fourth Quarter and Full Year 2024 Earnings Release Conference Call DALLAS, May 13, 2024 (GLOBE NEWSWIRE) -- CSW Industrials, Inc. (NASDAQ: CSWI) announced that it will release its earnings results for the fiscal fourth quarter and year ended March 31, 2024 on Thursday, May 23, 2024, before the market opens. The Company will host a conference call the same day at 10:00 am Eastern Time to discuss the results. Participants may access the call at 1-877-407-0784, international callers may use 1-201-689-8560, and request to join the CSW Industrials ear...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.